FDA officials to speak at conference

Share this article:
DTC Perspectives will host the third annual Achieving DTC Success conference Nov. 10-11 at the Westin Princeton Hotel in Princeton, N.J.
Among the event's scheduled speakers are two representatives from the FDA's Division of Drug Marketing, Advertising and Communications: Kathryn Aikin, a social science analyst, and Melissa Moncavage, the DTC review group leader. Ed Slaughter, director of market research at Prevention magazine and Lilly's Holly Sullivan, a senior marketing professional on Cialis, also will give presentations. The winners of the Perspectives On Excellence (POE) awards will be announced at an awards dinner on the first evening of the conference.
Bob Ehrlich, chief executive of DTC Perspectives, will address the changing role of DTC in 2005. The discussion will focus on what marketers need to do to face the tough 2005 DTC environment.
Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...